MarketBeat Week in Review – 7/15 - 7/19 IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress ...
Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and ...
Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results